QuantuMDx Takes Centre Stage at GIS23 Summit: Transforming Point-of-Care Molecular Diagnostics

Read More

QuantuMDx receives CTDA approval for sale of Q-POC™

Read More

QuantuMDx & Menarini Announce Exclusive Distribution Agreement

Read More

QuantuMDx & Sansure Biotech Enters into Agreement

Read More

QuantuMDx announces webinar: Rising to the challenge

Read More

QuantuMDx’s Q-POC™ Platform Shortlisted for SelectScience Clinical Scientists’ Choice Awards

Read More

Elaine Warburton OBE Wins InspiringFifty Europe 2022 Award

Read More

QuantuMDx wins Special Recognition Award at the 2022 Med-Tech Innovation Awards

Read More

QuantuMDx launches New PCR Respiratory Panel 

Read More

QuantuMDx wins MediLink Award 2022

Read More

New Website Launch

Read More

QuantuMDx wins two Bionow Awards 2021

Read More

QuantuMDx Wins Made in North East Medical Life Sciences Award 2022

Read More

SARS-CoV-2 RT-PCR Detection Assay receives CTDA legislation approval

Read More

Martin Walton appointed as Chief Financial Officer

Read More

Q-POC™ SARS-CoV-2 assay receives CTDA legislation approval

Read More

QuantuMDx confirm its diagnostic tests remain able to detect all known variants of COVID-19 including the new variant from South Africa, B.1.1.529

Read More

QuantuMDx secures £15 million equity investment from Vita Spring and enters into Cooperation Agreement discussions with Sansure Biotech

Read More

QuantuMDx partners with Cignpost Diagnostics

Read More

QuantuMDx launches Q-POC™ – a PCR diagnostic system

Read More

QuantuMDx included on PHE Microbiology Framework

Read More

Mirre de Noo appointed as non-executive director

Read More

QuantuMDx completes £11m funding round

Read More

Prime Minister, Boris Johnson visits QuantuMDx

Read More